• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用深度学习技术和临床因素预测乳腺钼靶检查中BI-RADS 4A阳性病变的新研究。

Novel study on the prediction of BI-RADS 4A positive lesions in mammography using deep learning technology and clinical factors.

作者信息

Ouyang Rushan, Liao Tingting, Yang Yuting, Lin Xiaohui, Zhou Xuhui, Ma Jie

机构信息

Department of Radiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.

Department of Radiology, Shenzhen People's Hospital, Shenzhen, China.

出版信息

Quant Imaging Med Surg. 2024 Dec 5;14(12):8864-8877. doi: 10.21037/qims-24-1075. Epub 2024 Nov 27.

DOI:10.21037/qims-24-1075
PMID:39698623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11652064/
Abstract

BACKGROUND

The classification of Breast Imaging Reporting and Data System (BI-RADS) category 4A lesions in mammography is complicated by subjective interpretations and unclear criteria, which can lead to potential misclassifications and unnecessary biopsies. Thus, more accurate assessment methods need to be developed. This study aimed to improve the classification prediction of BI-RADS 4A positive lesions in mammography by combining deep learning (DL) technology with relevant clinical factors.

METHODS

A retrospective analysis of 590 patients diagnosed with BI-RADS 4A at Shenzhen People's Hospital and Shenzhen Luohu People's Hospital was conducted, and a multi-faceted approach was employed to construct a robust predictive model. The patients were divided into training, validation, and external validation sets. The classification results from a DL system applied to mammography were recorded, and data on relevant clinical factors were collected. Univariate and multivariate logistic regression analyses were performed to identify the independent predictive factors. A predictive model and nomogram integrating these factors were developed. Assessment metrics, such as the areas under the curve (AUCs), calibration curves, and a decision curve analysis (DCA), were employed to evaluate the diagnostic performance, calibration, and clinical net benefit of the model. External validation was conducted to assess the generalization ability of the model.

RESULTS

Four independent predictive factors (i.e., age, nipple discharge, ultrasound BI-RADS assessment, and DL system classification results) were identified and included in the predictive model. The model showed commendable diagnostic performance with AUC values of 0.85, 0.82, and 0.84 for the training, validation, and external validation sets, respectively. There were no statistically significant differences in the AUCs of the predictive model between the training set, and the internal and external validation sets (P=0.543 and 0.842, respectively). The calibration curves showed excellent calibration in the training, validation, and external validation sets, indicating a minimal deviation between the predicted and actual positive risk probabilities (P=0.906, 0.890, and 0.769, respectively). The DCA results illustrated the clinical net benefit of the model for risk thresholds greater than 0.15 and less than 0.70 in both the internal validation and external validation sets.

CONCLUSIONS

Our predictive model, which incorporated age, nipple discharge, ultrasound BI-RADS assessment, and DL system classification results, emerged as a powerful tool for accurately predicting BI-RADS 4A positive lesions. Its application holds significant promise in helping radiologists enhance diagnostic precision and reduce unnecessary biopsies in BI-RADS 4A positive lesion cases.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/272d59f47a5a/qims-14-12-8864-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/411a88986e40/qims-14-12-8864-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/ec92bf293c1b/qims-14-12-8864-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/e1a7b2332522/qims-14-12-8864-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/0e5a8d3a4685/qims-14-12-8864-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/2d37bcf91d97/qims-14-12-8864-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/91a4d747ae1b/qims-14-12-8864-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/272d59f47a5a/qims-14-12-8864-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/411a88986e40/qims-14-12-8864-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/ec92bf293c1b/qims-14-12-8864-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/e1a7b2332522/qims-14-12-8864-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/0e5a8d3a4685/qims-14-12-8864-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/2d37bcf91d97/qims-14-12-8864-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/91a4d747ae1b/qims-14-12-8864-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415a/11652064/272d59f47a5a/qims-14-12-8864-f7.jpg
摘要

背景

乳腺影像报告和数据系统(BI-RADS)4A类病变在乳腺钼靶检查中的分类因主观解读和标准不明确而变得复杂,这可能导致潜在的错误分类和不必要的活检。因此,需要开发更准确的评估方法。本研究旨在通过将深度学习(DL)技术与相关临床因素相结合,改进乳腺钼靶检查中BI-RADS 4A阳性病变的分类预测。

方法

对在深圳市人民医院和深圳市罗湖区人民医院诊断为BI-RADS 4A的590例患者进行回顾性分析,并采用多方面方法构建一个强大的预测模型。将患者分为训练集、验证集和外部验证集。记录应用于乳腺钼靶检查的DL系统的分类结果,并收集相关临床因素的数据。进行单因素和多因素逻辑回归分析以确定独立预测因素。开发了一个整合这些因素的预测模型和列线图。采用曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)等评估指标来评估模型的诊断性能、校准和临床净效益。进行外部验证以评估模型的泛化能力。

结果

确定了四个独立预测因素(即年龄、乳头溢液、超声BI-RADS评估和DL系统分类结果)并纳入预测模型。该模型在训练集、验证集和外部验证集的AUC值分别为0.85、0.82和0.84,显示出良好的诊断性能。训练集与内部和外部验证集之间预测模型的AUCs无统计学显著差异(分别为P = 0.543和0.842)。校准曲线在训练集、验证集和外部验证集中显示出良好的校准,表明预测的和实际的阳性风险概率之间偏差最小(分别为P = 0.906、0.890和0.769)。DCA结果表明,在内部验证和外部验证集中,对于大于0.15且小于0.70的风险阈值,该模型具有临床净效益。

结论

我们的预测模型纳入了年龄、乳头溢液、超声BI-RADS评估和DL系统分类结果,成为准确预测BI-RADS 4A阳性病变的有力工具。其应用有望帮助放射科医生提高诊断准确性,并减少BI-RADS 4A阳性病变病例中不必要的活检。

相似文献

1
Novel study on the prediction of BI-RADS 4A positive lesions in mammography using deep learning technology and clinical factors.利用深度学习技术和临床因素预测乳腺钼靶检查中BI-RADS 4A阳性病变的新研究。
Quant Imaging Med Surg. 2024 Dec 5;14(12):8864-8877. doi: 10.21037/qims-24-1075. Epub 2024 Nov 27.
2
An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A Lesions.一种改进的列线图,以降低乳腺影像报告和数据系统超声4A类病变活检假阳性率。
Cancer Control. 2022 Jan-Dec;29:10732748221122703. doi: 10.1177/10732748221122703.
3
Ultrasound-based deep learning radiomics for multi-stage assisted diagnosis in reducing unnecessary biopsies of BI-RADS 4A lesions.基于超声的深度学习影像组学用于多阶段辅助诊断以减少BI-RADS 4A类病变的不必要活检
Quant Imaging Med Surg. 2025 Mar 3;15(3):2512-2528. doi: 10.21037/qims-24-580. Epub 2025 Feb 7.
4
A deep learning model integrating mammography and clinical factors facilitates the malignancy prediction of BI-RADS 4 microcalcifications in breast cancer screening.深度学习模型整合乳腺 X 线摄影和临床因素有助于预测乳腺癌筛查中 BI-RADS 4 微钙化的恶性程度。
Eur Radiol. 2021 Aug;31(8):5902-5912. doi: 10.1007/s00330-020-07659-y. Epub 2021 Jan 26.
5
Biopsy or Follow-up: AI Improves the Clinical Strategy of US BI-RADS 4A Breast Nodules Using a Convolutional Neural Network.活检还是随访:使用卷积神经网络,人工智能改善了 US BI-RADS 4A 乳腺结节的临床策略。
Clin Breast Cancer. 2024 Jul;24(5):e319-e332.e2. doi: 10.1016/j.clbc.2024.02.003. Epub 2024 Feb 20.
6
Ultrasound-based deep learning in the establishment of a breast lesion risk stratification system: a multicenter study.基于超声的深度学习在建立乳腺病变风险分层系统中的应用:一项多中心研究
Eur Radiol. 2023 Apr;33(4):2954-2964. doi: 10.1007/s00330-022-09263-8. Epub 2022 Nov 23.
7
A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI.一种针对非肿块性乳腺病变的风险预测分层方法,结合了超声、乳腺X线摄影和MRI的临床特征及影像特征。
Front Oncol. 2024 Oct 17;14:1337265. doi: 10.3389/fonc.2024.1337265. eCollection 2024.
8
Deep learning combining mammography and ultrasound images to predict the malignancy of BI-RADS US 4A lesions in women with dense breasts: a diagnostic study.深度学习结合乳腺 X 线摄影和超声图像预测致密乳腺 BI-RADS US 4A 病变的恶性程度:一项诊断研究。
Int J Surg. 2024 May 1;110(5):2604-2613. doi: 10.1097/JS9.0000000000001186.
9
A new nomogram for predicting the malignant diagnosis of Breast Imaging Reporting and Data System (BI-RADS) ultrasonography category 4A lesions in women with dense breast tissue in the diagnostic setting.一种用于预测诊断环境中乳腺致密组织女性乳腺影像报告和数据系统(BI-RADS)超声4A类病变恶性诊断的新列线图。
Quant Imaging Med Surg. 2021 Jul;11(7):3005-3017. doi: 10.21037/qims-20-1203.
10
A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.一种双模态列线图作为辅助工具,用于减少超声和乳腺 X 线摄影 BI-RADS 评估不一致时不必要的乳腺活检。
Eur Radiol. 2024 Apr;34(4):2608-2618. doi: 10.1007/s00330-023-10255-5. Epub 2023 Oct 16.

引用本文的文献

1
Value of deep learning model for predicting Breast Imaging Reporting and Data System 3 and 4A lesions on mammography.深度学习模型对乳腺钼靶摄影中乳腺影像报告和数据系统3类及4A类病变的预测价值。
Quant Imaging Med Surg. 2025 May 1;15(5):4047-4058. doi: 10.21037/qims-24-1523. Epub 2025 Apr 25.

本文引用的文献

1
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.欧洲乳腺不确定恶性潜能病变(B3 病变)诊治和随访指南(EUSOMA、EUSOBI、ESP(BWG)和 ESSO 联合制定)。
Eur J Surg Oncol. 2024 Jan;50(1):107292. doi: 10.1016/j.ejso.2023.107292. Epub 2023 Nov 27.
2
An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A Lesions.一种改进的列线图,以降低乳腺影像报告和数据系统超声4A类病变活检假阳性率。
Cancer Control. 2022 Jan-Dec;29:10732748221122703. doi: 10.1177/10732748221122703.
3
High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
高时间分辨率 DCE-MRI 提高了 BI-RADS 4 类乳腺内及周围病变的评估能力。
BMC Med Imaging. 2023 Apr 19;23(1):58. doi: 10.1186/s12880-023-01015-4.
4
Application of Deep Learning to Reduce the Rate of Malignancy Among BI-RADS 4A Breast Lesions Based on Ultrasonography.深度学习在降低基于超声 BI-RADS 4A 乳腺病变恶性率中的应用。
Ultrasound Med Biol. 2022 Nov;48(11):2267-2275. doi: 10.1016/j.ultrasmedbio.2022.06.019. Epub 2022 Aug 30.
5
Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.《诊断成像方式在现代乳房肿瘤筛查、诊断和管理中的应用》——第 1 份中东欧乳腺癌专业共识声明
Pathol Oncol Res. 2022 Jun 8;28:1610382. doi: 10.3389/pore.2022.1610382. eCollection 2022.
6
Comprehensive quantitative malignant risk prediction of pure grouped amorphous calcifications: clinico-mammographic nomogram.单纯性成簇无定形钙化的综合定量恶性风险预测:临床乳腺钼靶列线图
Quant Imaging Med Surg. 2022 May;12(5):2672-2683. doi: 10.21037/qims-21-797.
7
Downgrade BI-RADS 4A Patients Using Nomogram Based on Breast Magnetic Resonance Imaging, Ultrasound, and Mammography.基于乳腺磁共振成像、超声和乳腺X线摄影的列线图对BI-RADS 4A级患者进行降级评估。
Front Oncol. 2022 Jan 27;12:807402. doi: 10.3389/fonc.2022.807402. eCollection 2022.
8
Association between quantitative and qualitative image features of contrast-enhanced mammography and molecular subtypes of breast cancer.对比增强乳腺钼靶摄影的定量和定性图像特征与乳腺癌分子亚型之间的关联。
Quant Imaging Med Surg. 2022 Feb;12(2):1270-1280. doi: 10.21037/qims-21-589.
9
Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams.人工智能系统减少了乳腺超声检查中假阳性结果的出现。
Nat Commun. 2021 Sep 24;12(1):5645. doi: 10.1038/s41467-021-26023-2.
10
A new nomogram for predicting the malignant diagnosis of Breast Imaging Reporting and Data System (BI-RADS) ultrasonography category 4A lesions in women with dense breast tissue in the diagnostic setting.一种用于预测诊断环境中乳腺致密组织女性乳腺影像报告和数据系统(BI-RADS)超声4A类病变恶性诊断的新列线图。
Quant Imaging Med Surg. 2021 Jul;11(7):3005-3017. doi: 10.21037/qims-20-1203.